March 9th, 2022: Casualty Underwriting: The Original ESG In their latest article with Carrier Management, David Loughran and Robert Reville examine a topic that is top of mind for investors,…
read morePraedicat Posts on News Article
November 24th, 2021: What Do You Do With Emerging Interest Risks? What’s interesting to scientists should always be of interest to liability insurers. That’s the message our own Dr. Adam…
read moreAugust 24th, 2021: PFAS Litigation Levels Already at Epic Proportions PFAS litigation has reached epic proportions. Praedicat recently completed a massive data collection for our PFAS Litigation Tracker, a tool…
read moreMay 2021 – Climate change is here and so is climate-related litigation. But what does climate change have to do with the recent lawsuits filed against baby food manufacturers? As…
read moreMay 25th, 2021: Opioids Are the Next Tobacco. Are Antibiotics the Next Opioids? In our most recent Carrier Management article, Praedicat’s Senior Scientist and VP of Modeling, Dr. Adam Grossman and…
read moreApril 2021 – Per- and polyfluoroalkyl substances (PFAS) is a Litagion© Praedicat has been monitoring through our Emerging Risk lifecycle for some time. In an AM Best article, “On High…
read moreApril 5th, 2021: In the latest Carrier Management article, Pandemic Risk: Finding the Opportunity in Liability, Adam Grossman, VP of Modeling and Senior Scientist at Praedicat, and Nita Madhav, CEO…
read moreMarch 3rd, 2021: In the Leader’s Edge article, Taming the Casualty Industry, Michael Fitzpatrick sits down with Praedicat CEO Dr. Robert Reville for a Q&A session where Bob fields a…
read moreFebruary 22, 2021: In the Carrier Management article, Emerging Damage: The Case of Melamine, our CEO Dr. Robert Reville, Senior Scientist and VP of Modeling, Dr. Adam Grossman and Senior…
read moreOctober 13th, 2020: The APCIA article, “Lessons Learned: What COVID-19 has Taught the Re/Insurance Industry” summarizes and expands upon last week’s Intelligent Insurer’s Re/Insurance Lounge panel discussion, “COVID-19 Litigation and…
read moreOctober 4th, 2020: In the RIMS Risk Management Monitor article, ‘‘Take-Home COVID-19’ Claims: Preparing for a Second Wave of Coronavirus Litigation’, Praedicat Head of Product and Chief Economist, Dr. David Loughran deliberates…
read moreSeptember 28th, 2020: In the Reuters article, ‘Take Home’ Lawsuits Over COVID Infections Could be Costly for U.S. Employers, Praedicat CEO Robert Reville provides results from Praedicat’s suite of take-home COVID-19 scenarios. The Reuters’ article cites…
read more